Susquehanna International Group, LLP Bio N Tech Se Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Bio N Tech Se stock. As of the latest transaction made, Susquehanna International Group, LLP holds 14,130 shares of BNTX stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,130

Previous 10,650 32.68%

Holding current value

$1.45 Million

Previous $969,000 55.21%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$86.65 - $120.54 $301,542 - $419,479	3,480 Added 32.68%	14,130 $1.5 Million
Q1 2025 May 14, 2025	BUY	$91.06 - $126.88 $230,290 - $320,879	2,529 Added 31.14%	10,650 $969,000
Q4 2024 Feb 14, 2025	SELL	$99.72 - $122.68 $9.66 Million - $11.9 Million	-96,888 Reduced 92.27%	8,121 $925,000
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $7.73 Million - $12.3 Million	98,646 Added 1550.31%	105,009 $12.5 Million
Q2 2024 Aug 15, 2024	SELL	$80.36 - $102.87 $7.38 Million - $9.45 Million	-91,843 Reduced 93.52%	6,363 $511,000
Q1 2024 May 07, 2024	BUY	$88.96 - $112.35 $8.74 Million - $11 Million	98,206 New	98,206 $9.06 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $1.58 Million - $2.01 Million	16,069 Added 13.53%	134,807 $14.6 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $6 Million - $7.58 Million	58,483 Added 97.06%	118,738 $12.8 Million
Q1 2023 May 16, 2023	SELL	$122.57 - $153.67 $4.31 Million - $5.4 Million	-35,159 Reduced 36.85%	60,255 $7.51 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $896,041 - $1.41 Million	7,566 Added 8.61%	95,414 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $39.5 Million - $56.7 Million	-309,657 Reduced 77.9%	87,848 $11.8 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $7.65 Million - $11.6 Million	-62,063 Reduced 13.5%	397,505 $59.3 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $8.61 Million - $15.8 Million	-68,215 Reduced 12.92%	459,568 $78.4 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $86.6 Million - $145 Million	-399,558 Reduced 43.09%	527,783 $136 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $48.6 Million - $106 Million	236,170 Added 34.17%	927,341 $253 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $30.1 Million - $64.2 Million	265,700 Added 62.45%	691,171 $155 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $16.7 Million - $23.3 Million	-195,273 Reduced 31.46%	425,471 $46.5 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $11.1 Million - $19.7 Million	151,992 Added 32.42%	620,744 $50.6 Million
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $19 Million - $34.2 Million	328,684 Added 234.66%	468,752 $32.5 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $5.4 Million - $9.35 Million	140,068 New	140,068 $9.35 Million

Others Institutions Holding BNTX

# of Institutions

321

Shares Held

40.9M

Call Options Held

1.38M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Bio N Tech Se Transaction History